[1]
2025. Compulsory Licensing of Pharmaceuticals in the Andean Community: Critical Analysis of the Regulatory Framework and Proposal for Objective Criteria. Revista Iberoamericana de la Propiedad Intelectual. 22 (Jun. 2025), 37–84. DOI:https://doi.org/10.26422/RIPI.2025.2200.alc.